ASP Isotopes Inc. has completed the construction of a silicon-28 enrichment facility in Pretoria, South Africa, and has started the commissioning phase of the facility's construction and start-up. This development is in line with the company's previously communicated timelines.
The company now expects the plant to have an annual capacity of greater than 50 kilograms per year of 28Si enriched to 99.995%, a significant increase from its previous guidance of greater than 10 kilograms per year.
ASP Isotopes has signed two purchase agreements with US-based customers for kilogram quantities of silicon-28 and is in discussions with multiple other global customers for kilogram quantities, with the first deliveries of commercial quantities anticipated in the first half of 2025.
The silicon-28 enrichment facility is managed under a comprehensive safeguard agreement with the International Atomic Energy Agency (IAEA), and its representatives have visited and inspected the facility.
The company's proprietary technology can enrich isotopes of low atomic mass, such as silane (SiH4), as well as isotopes of heavier masses. ASP Isotopes believes that its finished product will be of higher quality and may be used by semiconductor companies without the need for additional chemical conversion processes.
ASP Isotopes has already signed two supply agreements with US-based customers for highly enriched silicon-28 and is in discussions with multiple other potential customers for the supply of highly enriched silicon-28. The company expects to sign more agreements during the next six months.
The company expects to build multiple silicon-28 enrichment facilities of larger nameplate capacity in multiple countries, including Iceland and the United States, assuming the demand for silicon-28 grows.
The facility contains several proprietary components, including hermetically sealed, oil-free, helium-tight centrifugal compressors, pressure actuated relief (PAR) valves, molar mass meters, and laminar flow meters.
ASP Isotopes is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The company's initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Today the company's shares have moved -19.7% to a price of $6.14. If you want to know more, read the company's complete 8-K report here.
